Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterization of Imiquimod 3.75% as a Surrogate Model of Itch
NCT03943407Withdrawn
- Sponsor
- Aalborg University
- Start
- Nov 2019
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Randomised, double-blind trial (4 arms), sponsored by Aalborg University. Primary endpoints: Superficial blood perfusion up to 19 days, Trans-epidermal Water Loss up to 19 days and 5 more. Planned start Nov 2019; status: withdrawn.
Beyond the preview
Go deeper on NCT03943407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03943407.